CCM
TTOO

Coe Capital Management’s T2 Biosystems, Inc TTOO Stock Holding History

Coe Capital Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$36K Hold
6
– – 0.03% 107
2021
Q1 		$49K Hold
6
– – 0.05% 104
2020
Q4 		$38K Buy
+6
New +$36.7K 0.04% 87

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KFS
Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Coe Capital Management's TTOO Position: Q2 2021 in Review

Coe Capital Management held its T2 Biosystems, Inc (TTOO) position steady in Q2 2021 at 6 shares worth $36K. The position accounts for 0.03% of the portfolio, ranked #107.

Coe Capital Management first reported a position in TTOO in Q4 2020 and has held it in 3 quarters since. The position peaked at $49K in Q1 2021. 78 funds tracked by Wall St. Rank hold TTOO as of Q2 2021.

  • Coe Capital Management held 6 shares of T2 Biosystems, Inc worth $36K as of Q2 2021.
  • Coe Capital Management left its T2 Biosystems, Inc share count unchanged in Q2 2021.
  • T2 Biosystems, Inc made up 0.03% of Coe Capital Management's portfolio in Q2 2021, its #107 holding.
  • Coe Capital Management first reported a position in T2 Biosystems, Inc in Q4 2020 and has held it in 3 quarters since.
  • Coe Capital Management's T2 Biosystems, Inc position peaked at $49K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2021.

Based on Coe Capital Management's 13F filing for Q2 2021, filed 22 Jul 2021.